摘要
致病性大肠杆菌对全球公共卫生构成严重威胁,随着抗生素耐药性的增加尤其危险。β-葡萄糖苷酶(GUS)和其他一些糖苷酶可以作为检测大肠杆菌的生物标志物或指标。探针由一个糖基残基(识别基团)、一个标签或报告基团和一个通常是直接糖苷键的连接组成,是强大的分析工具。当相应的糖苷酶水解糖苷键时,这些探针不可逆地释放可检测的标签或报告分子。目前已开发出多种此类糖苷酶探针用于大肠杆菌的检测或开发出各种相应的检测方法。本文综述了该领域的最新进展,包括显色、荧光、发光和电化学糖苷酶底物的开发和应用。探讨了大肠杆菌检测探针的发展面临的挑战和机遇。
关键词: 细菌病原体,糖苷酶底物,显色底物,荧光底物,发光底物,电化学底物
Current Medicinal Chemistry
Title:Recent Advances in Glycosidase Probes Used in Escherichia Coli Detection
Volume: 28 Issue: 26
关键词: 细菌病原体,糖苷酶底物,显色底物,荧光底物,发光底物,电化学底物
摘要: Pathogenic Escherichia coli poses a serious threat to global public health and is especially dangerous with the increase of antibiotic resistance. β-Glucuronidase (GUS) and some other glycosidases can serve as useful biomarkers or indicators for the detection of E. coli. The probes made up of a glycosyl residue (recognition group), a label or reporter group, and a linkage that is generally a direct glycosidic bond, are powerful analytical tools. Upon hydrolysis of the glycosidic linkages by the corresponding glycosidases, these probes irreversibly release detectable labels or reporter molecules. A variety of such glycosidase probes have been developed and applied for the detection of E. coli or the development of various corresponding detection methods. This paper provides an overview of recent advances in this field, covering the development and applications of chromogenic, fluorogenic, luminogenic, and electrochemical glycosidase substrates. The challenges and opportunities in the probe development for detection of E. coli are also discussed.
Export Options
About this article
Cite this article as:
Recent Advances in Glycosidase Probes Used in Escherichia Coli Detection, Current Medicinal Chemistry 2021; 28 (26) . https://dx.doi.org/10.2174/0929867328999201224111615
DOI https://dx.doi.org/10.2174/0929867328999201224111615 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Overview of Pediatric Epilepsy
Current Pediatric Reviews Exploring Optic Nerve Axon Regeneration
Current Neuropharmacology Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling
Current Medicinal Chemistry Chronic Cerebral Hypoperfusion Protects Against Acute Focal Ischemia,Improves Motor Function, and Results in Vascular Remodeling
Current Neurovascular Research Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates
Current Drug Targets - Cardiovascular & Hematological Disorders Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Cefixime-induced Oromandibular Dystonia in an Adult: A Case Report
Current Drug Safety Sepsis and Solid Organ Transplantation
Current Drug Targets University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology
Current Alzheimer Research Impact of Antiretroviral Therapy on the Relapse of Cryptococcosis and Survival of HIV-Infected Patients with Cryptococcal Infection
Current HIV Research Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Pathology of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
Current Neuropharmacology Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents
Recent Patents on Drug Delivery & Formulation Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry Drug Delivery to the Inner Ear: Strategies and Their Therapeutic Implications for Sensorineural Hearing Loss
Current Drug Delivery Inflammatory Bowel Disease: New Therapeutic Options in the Post Anti-TNFα Era
Current Drug Metabolism